Remi A. Nout
Molecular Biology · 2013–2020
A researcher in the Science corpus: 7 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 11 citations into it
- Pulmonary and Respiratory Medicine — 10 citations into it
Whom Remi A. Nout trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Remi A. Nout overall
Papers from Remi A. Nout's perspective
Ordered by how strongly the researchers Remi A. Nout trusts endorse each paper. Same corpus, a different order for every researcher.
- Ras, PI(3)K and mTOR signalling controls tumour cell growth (Nature)
- The phosphoinositide 3-kinase pathway. (Science)
- Integrated Genomic Characterization of Endometrial Carcinoma (Nature)
- Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer (Radiotherapy and Oncology)
- Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. (Radiotherapy and Oncology)
- REporting recommendations for tumour MARKer prognostic studies (REMARK) (British Journal of Cancer)
- Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (Annals of Oncology)
- Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial
- Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. (Gynecologic Oncology)
- A clinically applicable molecular-based classification for endometrial cancers (British Journal of Cancer)
Their papers
- Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy (2020) — 654 citations
- ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma (2020) — 1,756 citations
- The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies (2018) — 688 citations
- Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts (2016) — 726 citations
- ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer (2015) — 904 citations
- ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up. (2015) — 642 citations
- Post operative radiation therapy in endometrial carcinoma : reducing overtreatment and improving quality of life (2013) — 712 citations